The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Depression in Parkinson's disease - a review
Open accessAbstract
Major depression is present, at any given time, in 20-40% of Parkinson's disease (PD) patients, several times the prevalence in the general population. In addition, depression may precede the diagnosis of PD. These observations and reports of depression during deep brain stimulation of regions contiguous to the substantia nigra, as well as reports of dopamine agonist improving depression, suggest depression, rather than being mainly a psychological reaction to a debilitating disease, is part of PD. It is postulated that mesolimbic and mesocortical dopaminergic pathways that mediate affect, behavior, and cognition, contribute to depression in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease
Tessitore, A., Hariri, A. R., Fera, F., Smith, W. G., Chase, T. N., Hyde, T. M., Weinberger, D. R., & Mattay, V. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09099.2002 · Cited by 293
Burn, D. J. (2002) · Movement Disorders · doi:10.1002/mds.10114 · Cited by 223
Maricle, R. A., Nutt, J. G., Valentine, R. J., & Carter, J. H. (1995) · Neurology · doi:10.1212/wnl.45.9.1757 · Cited by 197
Research works printed but not linked: 79
- Leentjens AF, 2004, J Geriatric Psychiatry Neurol, 17, 120, 10.1177/0891988704267456 · DOI
- Ceravolo NA, 2004, Eur J Neurol, 11, 315, 10.1111/j.1468-1331.2004.00781.x · DOI · Paper page
- Burn DJ, 2002, Eur J Neurol, 9, 44, 10.1046/j.1468-1331.9.s3.6.x · DOI
- Zesiewicz TA, 2000, CNS Drugs, 13, 253, 10.2165/00023210-200013040-00003 · DOI
- Mayberg HS, 1995, Adv Neurol, 65, 49
- Brooks DJ, 2001, Curr Opin Neurol, 14, 465, 10.1097/00019052-200108000-00006 · DOI
- Cummings JL, 1992, Am J Psychiatry, 149, 443, 10.1176/ajp.149.4.443 · DOI · Paper page
- Oertel WH, 2001, Adv Neurol, 86, 373
- American Psychiatric Association, 1994, Statistical manual of mental disorders
- Edwards E, 2002, Depress Anxiety, 16, 39, 10.1002/da.10057 · DOI
- Lieberman AN, 1997, Barrow Neurol Inst Quart, 3, 27
- Hughes AJ, 1992, J Neurol Neurosurg Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
- Hamilton M, 1967, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
- 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L · DOI · Paper page
- Lieberman AN, 2004, Medimond International Proceedings, 59
- Cummings JL, 1997, Neurology, 48, S10, 10.1212/WNL.48.5_Suppl_6.10S · DOI · Paper page
- 10.1176/appi.neuropsych.13.2.187 · doi:10.1176/appi.neuropsych.13.2.187 · Paper page
- Menza MA, 1994, J Neuropsychiatry Clin Neurosci, 6, 165, 10.1176/jnp.6.2.165 · DOI
- 10.1007/s007020050005 · DOI · Paper page
- 10.1034/j.1600-0447.2001.00372.x · doi:10.1034/j.1600-0447.2001.00372.x · Paper page
- 10.1034/j.1600-0447.2002.02229.x · DOI
- Leentjens AF, 2003, Mov Disord, 18, 414, 10.1002/mds.10387 · DOI · Paper page
- Richard IH, 1996, J Neuropsychiatry Clin Neurosci, 8, 383, 10.1176/jnp.8.4.383 · DOI · Paper page
- Rijk C, 1998, Ned Tijdschr Geneeskd, 142, 27
- 10.1002/mds.1099 · DOI · Paper page
- 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5 · DOI · Paper page
- Weisskopf MG, 2003, Mov Disord, 18, 646, 10.1002/mds.10425 · DOI
- 10.1002/mds.870080415 · DOI
- 10.1176/appi.neuropsych.13.1.35 · doi:10.1176/appi.neuropsych.13.1.35
- Raudino F, 2001, Acta Neurol Scand, 104, 312, 10.1034/j.1600-0404.2001.00357.x · DOI · Paper page
- Harding AJ, 2002, Brain, 125, 2431, 10.1093/brain/awf251 · DOI · Paper page
- Jelling KA, 2003, Acta Neuropathol (Berl), 106, 191, 10.1007/s00401-003-0725-y · DOI · Paper page
- 10.1002/gps.755 · DOI · Paper page
- 10.1136/jnnp.73.6.636 · DOI · Paper page
- Levy ML, 1998, J Neuropsychiatry Clin Neurosci, 10, 314, 10.1176/jnp.10.3.314 · DOI · Paper page
- Molina JA, 2000, Mov Disord, 15, 869, 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I · DOI · Paper page
- Driver-Dunckley E, 2003, Neurology, 61, 422, 10.1212/01.WNL.0000076478.45005.EC · DOI · Paper page
- Kurlan R, 2004, Mov Disord, 19, 433, 10.1002/mds.10625 · DOI
- 10.1136/jnnp.68.4.423 · DOI · Paper page
- 10.1016/S0165-0173(99)00023-5 · DOI · Paper page
- Willner P, 1994, Psychopharmacology (Berl), 115, 454, 10.1007/BF02245568 · DOI
- Hughes TA, 2000, Neurology, 54, 1596, 10.1212/WNL.54.8.1596 · DOI · Paper page
- Hobson P, 2004, Mov Disord, 19, 1043, 10.1002/mds.20216 · DOI · Paper page
- Lieberman A, 1997, Parkinsonism Relat Disord, 3, 151, 10.1016/S1353-8020(97)00017-5 · DOI
- Marsh L, 2004, Neurology, 63, 293, 10.1212/01.WNL.0000129843.15756.A3 · DOI · Paper page
- 10.1146/annurev.neuro.9.1.357 · doi:10.1146/annurev.neuro.9.1.357 · Paper page
- Happe S, 2001, Acta Neurol Scand, 104, 275, 10.1034/j.1600-0404.2001.00024.x · DOI
- Tandberg E, 1998, Mov Disord, 13, 895, 10.1002/mds.870130606 · DOI · Paper page
- Oerlemans WG, 2002, Sleep Med, 3, 147, 10.1016/S1389-9457(01)00127-7 · DOI
- Comella CL, 1998, Neurology, 51, 526, 10.1212/WNL.51.2.526 · DOI · Paper page
- Schenck CH, 1996, Neurology, 46, 388, 10.1212/WNL.46.2.388 · DOI · Paper page
- Torack RM, 1988, Arch Neurol, 45, 497, 10.1001/archneur.1988.00520290025008 · DOI · Paper page
- Mann JJ, 1995, Clin Neuropharmacol, 18, S57, 10.1097/00002826-199501001-00008 · DOI
- Willner P, 1997, Int Clin Psychopharmacol, 12, S7, 10.1097/00004850-199707003-00002 · DOI · Paper page
- Fahn S, 1971, J Neurol Sci, 14, 427, 10.1016/0022-510X(71)90178-X · DOI · Paper page
- 10.1002/cne.902870308 · DOI · Paper page
- Nagatsu T, 1984, Adv Neurol, 40, 467
- Anderson KE, 2003, Curr Neurol Neurosci Rep, 3, 306, 10.1007/s11910-003-0007-z · DOI
- 10.1056/NEJM199905133401905 · DOI · Paper page
- Funkieweiz A, 2001, Neurology, 56, 274
- 10.1023/A:1016806711705 · DOI
- Kopell BH, 2004, J Clin Neurophysiol, 21, 51, 10.1097/00004691-200401000-00007 · DOI · Paper page
- Laitinen LV, 1988, Appl Neurophysiol, 51, 317
- 10.1016/S0140-6736(02)11339-0 · DOI · Paper page
- 10.1086/379978 · DOI · Paper page
- Degner D, 2004, Pharmacopsychiatry, 37, S39, 10.1055/s-2004-815509 · DOI
- 10.1001/jama.284.15.1931 · DOI · Paper page
- Cummings JL, 1999, J Neurol Sci, 163, 2, 10.1016/S0022-510X(98)00306-2 · doi:10.1016/s0022-510x(98)00306-2
- 10.1046/j.1468-1331.2003.00612.x · DOI · Paper page
- Guttman M, 2001, Parkinsonism Relat Disord, 7, 231, 10.1016/S1353-8020(00)00062-6 · doi:10.1016/s1353-8020(00)00062-6
- Szegedi A, 1997, Clin Neuropharmacol, 20, S36, 10.1097/00002826-199720001-00006 · DOI
- 10.1023/A:1009060800999 · DOI
- 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H · doi:10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h
- 10.1002/mds.10566 · DOI
- Ritter JL, 1997, Ann Clin Psychiatry, 9, 7, 10.3109/10401239709147768 · DOI
- Richard IH, 1997, Neurology, 48, 1070, 10.1212/WNL.48.4.1070 · DOI · Paper page
- 10.1016/S1389-9457(03)00058-3 · DOI
- Hening WA, 2004, Sleep, 27, 560, 10.1093/sleep/27.3.560 · DOI · Paper page
- Adler CH, 2004, Neurology, 62, 1405, 10.1212/01.WNL.0000120672.94060.F1 · DOI
Cited by
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494
Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease
Tadaiesky, M. T., Dombrowski, P. A., Figueiredo, C. P., Cargnin-Ferreira, E., Da Cunha, C., & Takahashi, R. N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.035 · Cited by 343
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Li, X., Shan, J., Zhang, W., Su, S., Yuwen, L., & Wang, L. (2017) · Small · doi:10.1002/smll.201602660 · Cited by 301
The role of dopamine in bipolar disorder
Cousins, D. A., Butts, K., & Young, A. H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00760.x · Cited by 291
Metadata
- Authors
- Lieberman, A.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2006-01
- Volume
- 113
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W2051737719
- Cited by
- 243
- References
- 8
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1 (tdm, 3530 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression in Parkinson's disease - a review. https://app.cochat.ai/papers/10.1111/j.1600-0404.2006.00536.x
- The paper
- Lieberman, A. (2006). Depression in Parkinson's disease - a review. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2006.00536.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.